Cargando…

Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing

Detalles Bibliográficos
Autores principales:	Pokorna, Petra, Lakka Klement, Giannoula, Vasikova, Alzbeta, Kanderova, Veronika, Jezova, Marta, Noskova, Kristyna, Mudry, Peter, Kyr, Michal, Merta, Tomas, Bajciova, Viera, Krenova, Zdenka, Palova, Hana, Valik, Dalibor, Zdrazilova Dubska, Lenka, Slaby, Ondrej, Sterba, Jaroslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384955/ https://www.ncbi.nlm.nih.gov/pubmed/35700412 http://dx.doi.org/10.1200/PO.21.00525

Ejemplares similares

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020)

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
por: Polaskova, Kristyna, et al.
Publicado: (2020)

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019)

Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
por: Noskova, Hana, et al.
Publicado: (2020)

Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
por: Pilatova, Katerina, et al.
Publicado: (2013)

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
por: Rihacek, Michal, et al.
Publicado: (2015)

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis
por: Múdry, Peter, et al.
Publicado: (2021)

Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report
por: Papez, Jan, et al.
Publicado: (2021)

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
por: Fedorova, Lenka, et al.
Publicado: (2019)

Future paradigms for precision oncology
por: Klement, Giannoula Lakka, et al.
Publicado: (2016)

Two sisters with cardiac‐urogenital syndrome secondary to pathogenic splicing variant in the MYRF gene with unaffected parents: A case of gonadal mosaicism?
por: Slaba, Katerina, et al.
Publicado: (2023)

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
por: Sterba, Martin, et al.
Publicado: (2023)

On the Treatment of Intermittent Fevers by Small Doses of Ipecacuanha
por: Dutt, Udhoy Chand
Publicado: (1872)

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
por: Hlavackova, Eva, et al.
Publicado: (2019)

Platelet Proteome and Tumor Dormancy: Can Platelets Content Serve as Predictive Biomarkers for Exit of Tumors from Dormancy?
por: Almog, Nava, et al.
Publicado: (2010)

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)

The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients
por: Ho, Vanda, et al.
Publicado: (2020)

Treatment of Intermittent Fevers by a Single Dose of Quinine
Publicado: (1850)

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
por: Veselska, Renata, et al.
Publicado: (2019)

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
por: Mudry, Peter, et al.
Publicado: (2017)

Clinical Studies with Non-Nauseating Doses of Ipecacuanha, Chiefly in Intermittents
por: Woodhull, Alfred A.
Publicado: (1875)

Clinical Studies with Non-Nauseating Doses of Ipecacuanha, Chiefly in Intermittents
por: Woodhull, Alfred A.
Publicado: (1875)

Novel Intermittent Dosing Burst Paradigm in Spinal Cord Stimulation
por: Deer, Timothy R., et al.
Publicado: (2020)

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
por: NERADIL, JAKUB, et al.
Publicado: (2015)

INTERMITTENT PULSE-DOSED TERBINAFINE IN THE TREATMENT OF TINEA CORPORIS AND/OR TINEA CRURIS
por: Shivakumar, V, et al.
Publicado: (2011)

Continuous or intermittent? On the dosing schedule of sunitinib for advanced renal cell carcinoma
por: Nozawa, Masahiro, et al.
Publicado: (2012)

An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
por: Skagerlind, Malin S. E., et al.
Publicado: (2017)

Effects of Various Doses of Caffeine Ingestion on Intermittent Exercise Performance and Cognition
por: Wang, Cuicui, et al.
Publicado: (2020)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

Genetic Algorithms as a Tool for Dosing Guideline Optimization: Application to Intermittent Infusion Dosing for Vancomycin in Adults
por: Colin, Pieter J., et al.
Publicado: (2020)

Effects of Pretreatment With Single-Dose or Intermittent Oxygen on Cisplatin-Induced Nephrotoxicity in Rats
por: Rasoulian, Bahram, et al.
Publicado: (2014)

Continuous Infusion versus Intermittent Dosing with Pantoprazole for Gastric Endoscopic Submucosal Dissection
por: Lee, Bong Eun, et al.
Publicado: (2019)

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report
por: Huemer, Florian, et al.
Publicado: (2016)

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
por: Reger de Moura, Coralie, et al.
Publicado: (2019)

Intermittent low-dose corticosteroid therapy for hidradenitis suppurativa: A case series
por: Erlendsson, Andrés M., et al.
Publicado: (2021)

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2011)

Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
por: Benzekry, Sebastian, et al.
Publicado: (2015)

Gibbs Energy and Gene Expression Combined as a New Technique for Selecting Drug Targets for Inhibiting Specific Protein–Protein Interactions
por: Rietman, Edward A., et al.
Publicado: (2023)

Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours
por: Hoh, C K, et al.
Publicado: (2014)

Intermittent Hypoxic Exposure with High Dose of Arginine Impact on Circulating Mediators of Tissue Regeneration
por: Zembron-Lacny, Agnieszka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7j40j14tndqdtuocfhlcgb1fj